
    
      A randomised multi-centre trial of tenofovir vs lamivudine vs tenofovir/lamivudine in
      antiretroviral naïve subjects with HIV/HBV co-infection over 48 weeks (Clinical Trial A).
      Plus, a 12 week viral kinetic sub-study comparing a sub-group of the patients on Clinical
      Trial A with a group of therapy naïve HBV mono-infected subjects (Substudy A1)
    
  